Fetal Cerebrovascular Autoregulation in Congenital Heart Disease and Association With Neonatal Neurobehavior
A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 104 participants.
Also called NCT05767385
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Phase 2/3
- Enrolled
- 104 participants
- Registry
-
NCT05767385
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT05767385. Allocation not applicable; no masking; primary purpose treatment. Start 2021-12-17 (actual); primary completion 2025-12-31 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Fetal Cerebrovascular Autoregulation in Congenital Heart Disease and Association With Neonatal Neurobehavior
- Condition
- Congenital Heart Disease in Children
- Condition
- Hypoxia
- Condition
- Neurodevelopmental Disorders
- Condition
- Complex Congenital Heart Disease
- Intervention (Procedure)
- Single Arm
- Intervention (Procedure)
- Neonatal Neurobehavioral Scale
- Lead sponsor
- University of Utah
- Collaborator
- Primary Children's Hospital
- Collaborator
- National Heart, Lung, and Blood Institute (NHLBI)
Record details
- Record id
cardio:ct-nct05767385- Content hash
11718ac8e41eb9a370ef330ed1f0cb6c5ac19b78c83b8a853af730b16fba2412